Dr. Heymach discusses the latest lung cancer approaches covering KRAS, refined TKI matching, antibody-drug conjugates, cell therapies, and cancer vaccines.
Brought to you by:
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
.png){kind=logo}
